Idenix Pharmaceuticals (IDIX) Higher After Positive Phase II Study Results
Tweet Send to a Friend
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) is 20% higher in pre-open trading after the company announced results from a phase II ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
